Research Compounds

NNMT (nicotinamide N-methyltransferase) inhibitor studied for its effects on adipogenesis, energy expenditure, and NAD+ pathway modulation in metabolic research.

Prohibitin-targeting peptide studied for proapoptotic effects on white adipose tissue vasculature in preclinical obesity research models.

C-terminal fragment of hGH (177–191) studied for lipolytic signaling without IGF-1 axis activation in metabolic and adipogenesis research.

Long-acting amylin analogue studied for satiety signaling, gastric emptying, and glucagon suppression in metabolic and obesity research models.

Studied in metabolic and endocrinology research for its interaction with incretin and energy-balance pathways in cell and animal models.

Dual compound research blend combining GLP-1 (Semaglutide) and Cagrilintide for synergistic incretin + amylin pathway research in metabolic models.

Dual GIP/GLP-1 receptor agonist studied extensively in metabolic research for energy regulation and body composition pathways.

Triple GIP/GLP-1/Glucagon receptor agonist investigated in advanced metabolic research models for its multi-receptor activity.

Triple/amylin receptor combination blend studying synergistic Retatrutide + Cagrilintide multi-pathway activity in advanced metabolic research models.

Lipolytic blend containing riboflavin and plant-derived compounds studied for localized adipocyte disruption signaling in aesthetic and metabolic research.

Lipotropic B-complex blend studied for fat metabolism enhancement and hepatic lipid processing in metabolic research. Contains MIC + B12.

Extended lipotropic blend with added carnitine studied for enhanced fatty acid transport and cellular energy metabolism research applications.

GLP-1/GCG dual receptor agonist studied in metabolic research for its combined energy expenditure and appetite regulation pathway activity.

Mitochondrial-derived peptide studied for its role in metabolic regulation, insulin sensitivity pathways, and cellular energy homeostasis.

ERR (estrogen-related receptor) agonist studied for mitochondrial biogenesis, exercise mimicry, and metabolic pathway activation in longevity and fitness research.

Dual GLP-1/Glucagon receptor agonist studied for energy expenditure, fat oxidation, and metabolic homeostasis pathway modulation in preclinical research.

Synthetic GHRH analogue studied for visceral adipose reduction, GH/IGF-1 axis stimulation, and body composition effects in metabolic research.